 Whitney Jackson
Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 22 | 2024 | 872 | 4.830 |
Why?
| | End Stage Liver Disease | 5 | 2024 | 82 | 2.660 |
Why?
| | Living Donors | 15 | 2023 | 295 | 1.970 |
Why?
| | Tissue and Organ Procurement | 6 | 2023 | 314 | 1.250 |
Why?
| | Sofosbuvir | 2 | 2017 | 59 | 1.020 |
Why?
| | Hepacivirus | 2 | 2017 | 258 | 0.910 |
Why?
| | Social Determinants of Health | 2 | 2024 | 251 | 0.860 |
Why?
| | Waiting Lists | 3 | 2024 | 262 | 0.860 |
Why?
| | Kidney Transplantation | 4 | 2023 | 701 | 0.810 |
Why?
| | Antiviral Agents | 2 | 2017 | 740 | 0.690 |
Why?
| | Fatty Liver | 1 | 2023 | 242 | 0.670 |
Why?
| | Liver Diseases | 1 | 2023 | 313 | 0.640 |
Why?
| | Ribavirin | 2 | 2017 | 91 | 0.610 |
Why?
| | Healthcare Disparities | 2 | 2024 | 651 | 0.600 |
Why?
| | Heterocyclic Compounds, 4 or More Rings | 1 | 2017 | 21 | 0.540 |
Why?
| | Carbamates | 1 | 2017 | 49 | 0.530 |
Why?
| | Simeprevir | 1 | 2016 | 9 | 0.510 |
Why?
| | Graft Survival | 6 | 2024 | 540 | 0.500 |
Why?
| | Colonic Polyps | 1 | 2016 | 88 | 0.470 |
Why?
| | Hepatitis C, Chronic | 1 | 2017 | 164 | 0.470 |
Why?
| | Tuberculosis, Hepatic | 1 | 2014 | 2 | 0.460 |
Why?
| | Cholestasis, Intrahepatic | 1 | 2014 | 39 | 0.440 |
Why?
| | Hepatitis | 1 | 2014 | 48 | 0.440 |
Why?
| | Adenoma | 1 | 2016 | 230 | 0.430 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2014 | 142 | 0.410 |
Why?
| | Liver | 10 | 2023 | 1940 | 0.410 |
Why?
| | Hepatitis C | 1 | 2016 | 263 | 0.410 |
Why?
| | Emigrants and Immigrants | 1 | 2014 | 137 | 0.370 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2016 | 351 | 0.370 |
Why?
| | Mycobacterium tuberculosis | 1 | 2014 | 317 | 0.350 |
Why?
| | Weight Loss | 1 | 2014 | 770 | 0.300 |
Why?
| | Treatment Outcome | 6 | 2024 | 10821 | 0.300 |
Why?
| | Retrospective Studies | 10 | 2024 | 15628 | 0.290 |
Why?
| | United States | 10 | 2024 | 14696 | 0.290 |
Why?
| | Severity of Illness Index | 3 | 2024 | 2838 | 0.270 |
Why?
| | Humans | 26 | 2024 | 137514 | 0.270 |
Why?
| | Ohio | 2 | 2016 | 154 | 0.240 |
Why?
| | Solitary Kidney | 1 | 2023 | 5 | 0.220 |
Why?
| | Risk Assessment | 2 | 2024 | 3439 | 0.210 |
Why?
| | Transplant Recipients | 2 | 2023 | 180 | 0.190 |
Why?
| | Sodium | 1 | 2022 | 218 | 0.180 |
Why?
| | Genotype | 2 | 2017 | 1920 | 0.180 |
Why?
| | Mitochondrial Encephalomyopathies | 1 | 2020 | 9 | 0.170 |
Why?
| | Graft Rejection | 1 | 2024 | 623 | 0.170 |
Why?
| | Thymidine Phosphorylase | 1 | 2020 | 14 | 0.170 |
Why?
| | Socioeconomic Factors | 1 | 2024 | 1286 | 0.160 |
Why?
| | Middle Aged | 7 | 2024 | 33355 | 0.160 |
Why?
| | Toxoplasmosis | 1 | 2019 | 39 | 0.160 |
Why?
| | Registries | 2 | 2024 | 2021 | 0.160 |
Why?
| | Nephrectomy | 1 | 2020 | 168 | 0.160 |
Why?
| | Biliary Atresia | 1 | 2020 | 163 | 0.150 |
Why?
| | Predictive Value of Tests | 1 | 2024 | 2039 | 0.150 |
Why?
| | Male | 9 | 2024 | 67718 | 0.150 |
Why?
| | Prognosis | 2 | 2024 | 4031 | 0.150 |
Why?
| | Premature Birth | 1 | 2021 | 331 | 0.140 |
Why?
| | Female | 10 | 2024 | 73162 | 0.140 |
Why?
| | Sustained Virologic Response | 1 | 2017 | 40 | 0.140 |
Why?
| | Adult | 7 | 2024 | 37821 | 0.130 |
Why?
| | Health Services Accessibility | 1 | 2024 | 976 | 0.130 |
Why?
| | Lung Transplantation | 1 | 2019 | 309 | 0.130 |
Why?
| | Tissue Donors | 1 | 2019 | 417 | 0.130 |
Why?
| | Drug Resistance, Viral | 1 | 2017 | 115 | 0.130 |
Why?
| | Drug Combinations | 1 | 2017 | 344 | 0.120 |
Why?
| | Hyperplasia | 1 | 2016 | 175 | 0.120 |
Why?
| | Drug Interactions | 1 | 2017 | 409 | 0.120 |
Why?
| | Viral Load | 1 | 2017 | 462 | 0.120 |
Why?
| | Precancerous Conditions | 1 | 2016 | 170 | 0.110 |
Why?
| | Case-Control Studies | 1 | 2022 | 3546 | 0.110 |
Why?
| | Vietnam | 1 | 2014 | 28 | 0.110 |
Why?
| | Liver Function Tests | 1 | 2014 | 114 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 892 | 0.110 |
Why?
| | Colonoscopy | 1 | 2016 | 247 | 0.110 |
Why?
| | Aged | 3 | 2024 | 23798 | 0.100 |
Why?
| | Mitochondria | 1 | 2020 | 947 | 0.100 |
Why?
| | Drug Therapy, Combination | 1 | 2016 | 1060 | 0.100 |
Why?
| | Recurrence | 1 | 2016 | 1060 | 0.100 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 1047 | 0.100 |
Why?
| | Biopsy | 1 | 2014 | 1132 | 0.090 |
Why?
| | Colorectal Neoplasms | 1 | 2016 | 799 | 0.070 |
Why?
| | Quality of Life | 1 | 2020 | 2870 | 0.070 |
Why?
| | Child | 3 | 2022 | 22037 | 0.070 |
Why?
| | Risk Factors | 2 | 2024 | 10356 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2681 | 0.050 |
Why?
| | Prospective Studies | 1 | 2016 | 7598 | 0.050 |
Why?
| | Young Adult | 2 | 2019 | 13243 | 0.050 |
Why?
| | Donor Selection | 1 | 2023 | 77 | 0.050 |
Why?
| | Adolescent | 2 | 2020 | 21555 | 0.040 |
Why?
| | Thymidine | 1 | 2020 | 60 | 0.040 |
Why?
| | Preoperative Care | 1 | 2022 | 356 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2023 | 5772 | 0.040 |
Why?
| | Esophageal Motility Disorders | 1 | 2020 | 27 | 0.040 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2019 | 41 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 685 | 0.040 |
Why?
| | Remission Induction | 1 | 2020 | 287 | 0.040 |
Why?
| | Chemoprevention | 1 | 2019 | 93 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2019 | 305 | 0.040 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2020 | 129 | 0.040 |
Why?
| | Pregnancy Outcome | 1 | 2021 | 413 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2022 | 1465 | 0.030 |
Why?
| | Pain | 1 | 2022 | 836 | 0.030 |
Why?
| | Infant | 2 | 2020 | 9467 | 0.030 |
Why?
| | Kidney | 1 | 2023 | 1472 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 614 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5139 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 6059 | 0.020 |
Why?
| | Pregnancy | 1 | 2021 | 6745 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2020 | 3722 | 0.020 |
Why?
|
|
Jackson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|